Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Brilacidin – A Winner in the Making with its novel Mechanism of action (MoA). The Host Defense Protein (HDP) mimic has a broad spectrum of activity and applicability in:
• Infectious diseases (Ph2b, Acute Bacterial Skin and Skin Structure Infection – ABSSSI,
including MRSA, and Gram-negative, e.g., CRE bacteria)
• Gastrointestinal diseases/Inflammation (Ulcerative proctitis / proctosigmoiditis, Ph2),
• Palliative Cancer/Dermatologic care (Oral Mucositis, Ph2)
• In several Dermatological diseases (including Hidradenitis Suppurativa /HS and acne).

http://cellceutix.com/cellceutix-phase-2-trial-initial-data-shows-potential-of-brilacidin-as-a-novel-anti-inflammatory-drug-candidate-for-the-induction-of-remission-of-mild-to-moderate-ulcerative-colitis/

http://cellceutix.com/cellceutix-expedites-phase-2-trial-of-brilacidin-om-for-oral-mucositis/

http://www.mpadvisor.com/xyz/Cellceutix_160826.pdf